
Agilent Doubles Down on Pathology With $950M Biocare Medical Acquisition
Agilent acquires Biocare Medical for $950M to expand pathology and immunohistochemistry capabilities. Deal expected accretive to EPS within 12 months, closing by Q4 2026.
Aacquisitionrevenue growth